.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India and France have officially launched the AI in Health Centre (IF-CAIH) at AIIMS, New Delhi. Specifically, Union Health Minister JP Nadda and French President Emmanuel Macron led the inauguration ceremony on Wednesday. This pioneering initiative aims to advance AI-driven research and medical education. Consequently, it strengthens bilateral cooperation in healthcare and emerging technologies between the two nations.
The IF-CAIH is designed to address complex healthcare challenges through clinical innovation. Furthermore, the center promotes interdisciplinary collaboration between top Indian and French institutions. President Macron emphasized the importance of building sovereign AI capacity during the event. He stated that both nations must develop their own trusted AI systems. Therefore, the center will focus on nurturing local talent and computing capacity.
The center prioritizes the ethical use of artificial intelligence in medicine. Moreover, President Macron highlighted the need for algorithm transparency to eliminate bias. This ensures that AI serves humanity while protecting vulnerable populations. Specifically, the initiative includes strong protections for children and a commitment to cultural diversity. In addition, the project aligns with the goals of the Rencontres Universitaires et Scientifiques de Haut Niveau forum.
Collaboration is at the heart of this new facility. AIIMS Delhi established the center under a joint MoU with Sorbonne University. Additionally, the Paris Brain Institute and the Indian Institute of Technology Delhi are key partners. These institutions will explore collaborative solutions in global health and brain research. Consequently, the partnership builds on ongoing cooperation in digital health and antimicrobial resistance. Minister JP Nadda reaffirmed India's commitment to fostering global knowledge exchange through this hub.
Q1: What is the primary focus of the Indo-French Centre for AI in Health?
The center focuses on advancing AI-driven research, medical education, and clinical innovation to solve global healthcare challenges.
Q2: Which institutions are involved in this bilateral collaboration?
The collaboration involves AIIMS Delhi, Sorbonne University, and the Paris Brain Institute, with support from IIT Delhi and the French Embassy.
Q3: Why did President Macron emphasize sovereign AI capacity?
He argued that nations must build their own trusted AI systems to ensure transparency and avoid total reliance on external technologies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India and France launch the Indo-French Centre for AI in Health at AIIMS Delhi to advance AI-driven research, medical education, and clinical innovation....
8 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
